PrimeRFP SCOUT · Federal Contract Recompete Brief

75D30126P20941TRIAL management SYSTEM for TB clinical research — Openclinica LLC

Openclinica LLC holds $2.2M across 3 federal awards, concentrated at Department of Health and Human Services (HHS). The prior award was single-bid — competitive dynamics may favor a challenge. Set-aside status: NONE. Recompete timing centers on the Apr 9, 2027 PoP end — agencies typically plan 12–18 months ahead.

Cdc Office Of Acquisition Services

Awarding office

Openclinica LLC

Recipient

Apr 9, 2027

PoP end

$343K

Obligated

$343K

Potential

541990

NAICS

DA10

PSC

NONE

Set-aside

1 bidders on last award

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Openclinica LLC — $90

Contract facts

NONE

Contract number75D30126P20941

AgencyCdc Office Of Acquisition Services

Awarding officeCdc Office Of Acquisition Services

Awarding agencyDepartment of Health and Human Services (HHS)

Funding agencyDepartment of Health and Human Services (HHS)

IncumbentOpenclinica LLC

CAGE9AU39

UEIVJWGYQDM2X28

NAICS541990

No full NAICS 541990 intel page yet. Browse NAICS intelligence

PSCDA10

Place of performanceATLANTA GA

Pricing typeFirm Fixed Price

Extent competedNot Competed Under SAP

Related solicitation75D301-26-Q-78853

PoP startApr 10, 2026

PoP end (current)Apr 9, 2027

Obligated$343K

Current value$343K

Potential value$343K

TRIAL MANAGEMENT SYSTEM FOR TB CLINICAL RESEARCH is a federal NONE award for Cdc Office Of Acquisition Services held by Openclinica LLC. Estimated value $343K ($343K obligated). Current period of performance ends Apr 9, 2027. Last award drew 1 bidder. Place of performance: ATLANTA GA. Related solicitation 75D301-26-Q-78853.

TRIAL MANAGEMENT SYSTEM FOR TB CLINICAL RESEARCH

Recompete timing

Public

● Expiring in 214 days

Current PoP ends Apr 9, 2027 (214 days remaining). Agencies typically plan 12–18 months ahead — at 7.0 months out, that window is already open. The buying decision is likely already in motion.

Incumbent footprint

Public record

Openclinica LLC — $2.2M obligated across 3 awards (firm-wide, all agencies).

Sole agency: Department of Health and Human Services (HHS)

Department of Health and Human Services (HHS)$2.2M · 100% of firm total

Open full company profile →

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

Frequently asked questions

What is contract 75D30126P20941?

75D30126P20941 (TRIAL management SYSTEM for TB clinical research) is a Cdc Office Of Acquisition Services award with a potential value of $343K, currently held by Openclinica LLC. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

Which office awarded 75D30126P20941?

Cdc Office Of Acquisition Services awarded 75D30126P20941 to Openclinica LLC (potential $343K).

Who is the incumbent on 75D30126P20941?

Openclinica LLC is the incumbent with $2.2M across 3 related awards in SCOUT’s public footprint. The current period of performance ends Apr 9, 2027.

When does Openclinica LLC’s 75D30126P20941 come up for recompete?

SCOUT tracks a period-of-performance end of Apr 9, 2027. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Seen enough? Run one full capture cycle on 75D30126P20941 — $90 for 90 days.

This page stays free. Pilot is the live layer: displacement scoring, recompete pipeline, Daily Brief, and SCOUT MCP for 90 days. If you already live in Claude or ChatGPT and only need live search, start MCP Explorer at $29/mo.

Start Pilot — $90

$1/day · one payment · no subscription

Use SCOUT in your AI client — $29/mo

Classify + search inside Claude, ChatGPT, Cursor

Compare plans

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of Jul 2, 2026 · refreshed monthlyLatest procurement action Apr 10, 2026